Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Smedley B.D. Stith A.Y. Nelson A.R. Committee on understanding and eliminating racial and ethnic disparities in health care. Unequal treatment: confronting racial and ethnic disparities in health care. National Academies Press (US), 2014
- Cancer Disparities. Published August 4, 2016.(Available at:) (Accessed July 25, 2021)
- American Society of Clinical Oncology policy statement: disparities in cancer care.J Clin Oncol. 2009; 27: 2881-2885
- Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.Gynecol Oncol. 2014; 133: 353-361
- Search healthy people - healthy people 2030.(Available at) (Accessed August 9, 2021)
- American Cancer Society.(Available at) (Accessed July 25, 2021)
- The growing burden of endometrial cancer: a major racial disparity affecting black women.Cancer Epidemiol Biomarkers Prev. 2015; 24: 1407-1415
- Cancer statistics for African Americans.CA Cancer J Clin. 2019; 69: 211-233
- Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.Gynecol Oncol. 2013; 130: 652-659
- Molecular carcinogenesis of endometrial cancer.Taiwan J Obstet Gynecol. 2007; 46: 26-32
- Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time.Cancer. 2009; 115: 1276-1285
- The National Cancer Data base report on endometrial carcinoma in African-American women.Cancer. 1998; 83: 2629-2637
- The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma.Gynecol Oncol. 2013; 128: 171-174
- Disparities in treatment and survival for women with endometrial cancer: a contemporary National Cancer Database registry analysis.Gynecol Oncol. 2016; 143: 98-104
- Role of bleeding recognition and evaluation in black-white disparities in endometrial cancer.Am J Obstet Gynecol. 2018; 219: 593.e1-4
- SEER cancer statistics review.National Cancer Institute, Bethesda, MD1975-2017 (Published online 2020)
- Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival.Am J Public Health. 2004; 94: 2104-2111
- Impact of quality of care on racial disparities in survival for endometrial cancer.Am J Obstet Gynecol. 2020; 223: 396.e1-3
- Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.Cancer. 2010; 116: 355-361
- Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group Study.Cancer. 2006; 107: 2197-2205
- Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas.Oncotarget. 2018; 9: 17093-17103
- Racial disparities in molecular subtypes of endometrial cancer.Gynecol Oncol. 2018; 149: 106-116
- The impact of race and comorbidity on survival in endometrial cancer.Cancer Epidemiol Biomarkers Prev. 2012; 21: 753-760
- The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.Br J Cancer. 2013; 108: 727-734
- The influence of comorbid conditions on racial disparities in endometrial cancer survival.Am J Obstet Gynecol. 2014; 211: 627.e1-9
- Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment.Gynecol Oncol. 2011; 123: 76-81
- Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.Gynecol Oncol. 2011; 122: 63-68
- The impact of race on survival in uterine serous carcinoma: a hospital-based study.Gynecol Oncol. 2011; 121: 577-580
- Cancer statistics, 2020.CA Cancer J Clin. 2020; 70: 7-30
- An international assessment of ovarian cancer incidence and mortality.Gynecol Oncol. 2013; 130: 107-114
- Racial health disparities in ovarian cancer: not just black and white.J Ovarian Res. 2017; 10: 58
- Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.Gynecol Oncol. 2012; 125: 19-24
- Racial disparities in ovarian cancer surgical care: a population-based analysis.Gynecol Oncol. 2011; 121: 364-368
- Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.Gynecol Oncol. 2021; 160: 10-15
- Racial disparities in the treatment of advanced epithelial ovarian cancer.Obstet Gynecol. 2013; 122: 1025-1032
- Racial disparities in treatment and survival from ovarian cancer.Cancer Epidemiol. 2019; 58: 77-82
- Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.Cancer. 2009; 115: 4210-4217
- Health care segregation, physician recommendation, and racial disparities in BRCA1/2 testing among women with breast cancer.J Clin Oncol. 2016; 34: 2610-2618
- Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.Cancer. 2017; 123: 2497-2505
- Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American cancer epidemiology study.Cancer. 2019; 125: 4442-4451
- Cervical cancer screening: who is not screened and why?.Am J Public Health. 1991; 81: 885-890
- Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.Cancer. 2003; 97: 1528-1540
- Racial disparities in HPV-related knowledge, attitudes, and beliefs among African American and white women in the USA.J Cancer Educ. 2019; 34: 66-72
- Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.PLoS One. 2017; 12: e0172548
- Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.Gynecol Oncol. 2018; 149: 4-11
- Ethnic disparities in cervical cancer survival among Texas women.J Womens Health. 2009; 18: 1577-1583
- Racial differences in cervical cancer survival in the Detroit metropolitan area.Cancer. 2008; 112: 1264-1271
- Black and white women in Maryland receive different treatment for cervical cancer.PLoS One. 2014; 9: e104344
- Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy.Gynecol Oncol. 1998; 71: 151-158
- Assessment of mediators of racial disparities in cervical cancer survival in the United States.Int J Cancer. 2016; 138: 2622-2630
- Factors associated with no surgery or radiation therapy for invasive cervical cancer in black and white women.Ethn Dis. 2000; 10: 248-256
- The influence of surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer.Am J Obstet Gynecol. 2011; 205: 225.e1-7
- Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.Gynecol Oncol. 2019; 154: 595-601
- Disparities among cervical cancer patients receiving brachytherapy.Obstet Gynecol. 2019; 134: 559-569
- Association of hospital volume with racial and ethnic disparities in locally advanced cervical cancer treatment.Obstet Gynecol. 2017; 129: 295-304
- Impact of facility volume on therapy and survival for locally advanced cervical cancer.Gynecol Oncol. 2014; 132: 416-422
- Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.Gynecol Oncol. 2016; 141: 516-523
- Diversity in clinical and biomedical research: a promise yet to be fulfilled.PLoS Med. 2015; 12: e1001918
- Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.Cancer. 2014; 120: 1091-1096
- Minority participation in Gynecologic Oncology Group (GOG) studies.Gynecol Oncol. 2015; 138: 441-444
- The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.Gynecol Oncol. 2016; 143: 611-616
- Investigating black-white disparities in gynecologic oncology: theories, conceptual models, and applications.Gynecol Oncol. 2018; 149: 78-83
- Medical advances and racial/ethnic disparities in cancer survival.Cancer Epidemiol Biomarkers Prev. 2009; 18: 2701-2708
Article info
Footnotes
Funding Support: NCI P20 CA233304 (DRR, ELB), the Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (DRR).
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
